Melanocytic naevi, other sites/unspecified

CD2_BENIGN_MELANOCYTIC_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D22.9&
Hospital discharge: ICD-9 216[8-9]A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D22.9&
Cause of death: ICD-9 216[8-9]A
Cause of death: ICD-8 $!$

1706

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1706

diagram downward connector

Check minimum number of events None

1706

diagram downward connector

Include endpoints None

1706

diagram downward connector
CD2_BENIGN_MELANOCYTIC_NOS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D22
Name in latin Naevus melanocyticus non specificatus

Summary Statistics

Key figures

All Female Male
Number of individuals 1706 1034 672
Unadjusted prevalence (%) 0.48 0.52 0.43
Mean age at first event (years) 50.90 47.00 56.91

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.71 [2.28, 6.04] 1.3e-7 79
15 years 0.02 2.16 [1.26, 3.69] 5.1e-3 42
5 years 0.00 2.55 [1.41, 4.62] 2.0e-3 20
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS – Melanocytic naevi, other sites/unspecified
GWS hits: 2

Survival analyses between endpoints

Plot

before Melanocytic naevi, other sites/unspecified
after Melanocytic naevi, other sites/unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Melanocytic naevi, other sites/unspecified